GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (OTCPK:MTLHF) » Definitions » 3-Year Book Growth Rate

MTLHF (Mitsubishi Chemical Group) 3-Year Book Growth Rate : 12.50% (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mitsubishi Chemical Group 3-Year Book Growth Rate?

Mitsubishi Chemical Group's Book Value per Share for the quarter that ended in Sep. 2024 was $8.55.

During the past 12 months, Mitsubishi Chemical Group's average Book Value per Share Growth Rate was 0.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was 12.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 6.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Mitsubishi Chemical Group was 13.50% per year. The lowest was -8.00% per year. And the median was 4.10% per year.


Competitive Comparison of Mitsubishi Chemical Group's 3-Year Book Growth Rate

For the Specialty Chemicals subindustry, Mitsubishi Chemical Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitsubishi Chemical Group's 3-Year Book Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Mitsubishi Chemical Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Mitsubishi Chemical Group's 3-Year Book Growth Rate falls into.



Mitsubishi Chemical Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Mitsubishi Chemical Group  (OTCPK:MTLHF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Mitsubishi Chemical Group 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Mitsubishi Chemical Group's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mitsubishi Chemical Group Business Description

Address
1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8251
Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.